IPR2020-01649
`Paper No. 24
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`____________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`____________
`
`EDWARDS LIFESCIENCES CORPORATION and
`EDWARDS LIFESCIENCES LLC,
`Petitioners,
`
`v .
`
`COLIBRI HEART VALVE LLC,
`Patent Owner.
`
`____________
`
`Case IPR2020-01649
`Patent 9,125,739
`____________
`
`Before the Honorable ERICA A. FRANKLIN, JAMES A. TARTAL,
`and ERIC C. JESCHKE,
`Administrative Patent Judges.
`
`
`PETITIONERS’ UPDATED EXHIBIT LIST
`
`
`
`
`
`
`
`

`

`UPDATED EXHIBIT LIST
`
`IPR2017-00060
`Paper No. 24
`
`EXHIBIT 1001 U.S. Patent No. 9,125,739 (Paniagua et al.)
`EXHIBIT 1002
`File History for U.S. Patent No. 9,125,739 (Paniagua et al.)
`EXHIBIT 1003 Andersen et al., Transluminal Implantation of Artificial Heart
`Valves. Description of a New Expandable Aortic Valve and
`Initial Results with Implantation by Catheter Technique in
`Closed Chest Pigs, European Heart Journal 13:704-708 (1992)
`EXHIBIT 1004 U.S. Patent No. 5,411,552 (Andersen et al.)
`EXHIBIT 1005 Bailey, Percutaneous Expandable Prosthetic Valves, Textbook
`of Interventional Cardiology, Chapter 75 (1994)
`EXHIBIT 1006 U.S. Patent No. 5,855,601 (Bessler et al.)
`EXHIBIT 1007 U.S. Patent No. 5,332,402 (Teitelbaum)
`EXHIBIT 1008 Moazami et al., Transluminal Aortic Valve Placement A
`Feasibility Study with a Newly Designed Collapsible Aortic
`Valve, ASAIO J., M381-385 (Sept.-Oct. 1996)
`EXHIBIT 1009 U.S. Patent Application Publication No. 2002/0032481 (Gabbay)
`EXHIBIT 1010 U.S. Patent No. 6,425,916 (Garrison et al.)
`EXHIBIT 1011 U.S. Patent No. 6,652,578 (Bailey et al.)
`EXHIBIT 1012 U.S. Patent No. 5,957,949 (Leonhardt et al.)
`EXHIBIT 1013
`Ebeid et al., Use of Balloon-Expandable Stents for Coarctation
`of the Aorta: Initial Results and Intermediate-Term Follow-Up,
`30 J. Am. C. Cardiology 7, 1847-52 (Dec. 1997)
`Edwards Receives European Approval for Advanced SAPIEN 3
`Valve (Jan. 27, 2014)
`EXHIBIT 1015 U.S. Patent Application Publication No. 2005/0113910
`(Paniagua et al.)
`EXHIBIT 1016 Rösch et al., The Birth, Early Years, and Future of
`Interventional Radiology, J. Vasc. Interv. Radiol., 14:841-853
`(2003)
`EXHIBIT 1017 U.S. Patent No. 6,908,481 (Cribier)
`EXHIBIT 1018
`File History for U.S. Patent No. 8,308,797 (Paniagua et al.)
`EXHIBIT 1019 U.S. Patent Application Publication No. 2001/0044633 (Klint)
`EXHIBIT 1020 Declaration of Steven L. Goldberg, M.D.
`
`EXHIBIT 1014
`
`
`
`1
`
`

`

`IPR2020-01649
`Paper No. 24
`
`EXHIBIT 1028
`
`EXHIBIT 1029
`
`EXHIBIT 1021 U.S. Patent No. 8,308,797 (Paniagua et al.)
`EXHIBIT 1022
`Infringement Chart from Colibri Heart Valve LLC v. Medtronic
`CoreValve LLC, No. 8:20-cv-847-DOC-JDE, D.I. 30-3 (C.D.
`Cal. June 12, 2020) (Exhibit A to First Amended Complaint).
`EXHIBIT 1023 U.S. Patent No. 6,730,118 (Spenser et al.)
`EXHIBIT 1024
`Press Release, Edwards Lifesciences Receives CE Mark for
`Edwards SAPIEN Transcatheter Heart Valve Edwards
`Lifesciences (Sept. 5, 2007)
`EXHIBIT 1025 Colibri’s Opposition to Medtronic’s Motion to Dismiss First
`Amended Complaint [DKT. 38], Colibri Heart Valve LLC v.
`Medtronic CoreValve LLC, No. 8:20-cv-847-DOC-JDE, D.I. 46
`(C.D. Cal. Aug. 14, 2020)
`EXHIBIT 1026 U.S. Patent No. 8,900,294 (Paniagua et al.)
`EXHIBIT 1027 CoreValve Receives CE Mark Approval for its ReValving™
`System and Announces Plans to Initiate Expanded Clinical
`Evaluation, Business Wire (May 16, 2007)
`Edwards SAPIEN XT Transcatheter Valve and Delivery Systems
`Receive CE Mark (Mar. 2, 2010)
`for First
`Edwards Lifesciences Receives FDA Approval
`Catheter-Based Aortic Heart Valve in the U.S. (Nov. 2, 2011)
`EXHIBIT 1030 Medtronic CoreValve® System Obtains Early FDA Approval on
`Exceptional Clinical Performance (Jan. 17, 2014)
`EXHIBIT 1031 Bonhoeffer et al., Percutaneous Replacement of Pulmonary
`Valve in a Right-Ventricle to Pulmonary-Artery Prosthetic
`Conduit with Valve Dysfunction, Lancet 356:1403-05 (2000)
`Pavcnik et al., Aortic and Venous Valve for Percutaneous
`Insertion, Min Invas Ther & Allied Technol 9(3/4) 287-92
`(2000)
`EXHIBIT 1033 Declaration of Megan E. Dellinger in Support of Petitioners’
`Motion for Admission Pro Hac Vice of Megan E. Dellinger
`Pursuant to 37 C.F.R. § 42.10
`Final Written Decision from Edwards Lifesciences Corp. et al. v.
`Boston Scientific Scimed, Inc., IPR2017-00060, Paper 64 (PTAB
`March 23, 2018)
`EXHIBIT 1035 USPTO implementation of an interim Director review process
`following Arthrex, available at
`https://www.uspto.gov/patents/patent-trial-and-appeal-
`board/procedures/uspto-implementation-interim-director-review
`
`EXHIBIT 1032
`
`EXHIBIT 1034
`
`
`
`2
`
`

`

`IPR2020-01649
`Paper No. 24
`
`EXHIBIT 1038
`
`(last accessed Sept. 9, 2021)
`EXHIBIT 1036 Reply Declaration of Steven L. Goldberg, M.D.
`EXHIBIT 1037 Cribier, The Development of Transcatheter Aortic Valve
`Replacement (TAVR), Glob Cardiol Sci Pract., Dec. 30, 2016
`FDA Clears Aortic, Mitral Valve-In-Valve Procedures for
`Sapien 3 TAVR Valve, available at
`https://www.dicardiology.com/article/fda-clears-aortic-mitral-
`valve-valve-procedures-sapien-3-tavr-valve (last accessed
`Sept. 9, 2021)
`EXHIBIT 1039 Deposition Transcript of Dr. Lakshmi Prasad Dasi (Aug. 25,
`2021)
`Petitioners’ Demonstrative Exhibits
`
`EXHIBIT 1040
`
`
`
`
`
`
`
`
`3
`
`

`

`
`
`
`
`
`
`
`
`Dated: December 1, 2021
`
`
`
`
`
`
`
`
`IPR2020-01649
`Paper No. 24
`
`
`
`
`
`Respectfully submitted,
`
`/s/ Brian P. Egan
` Brian P. Egan, Esq. (Reg. No. 54,866)
` Gregory S. Cordrey, Esq. (Reg. No. 44,089)
` Megan E. Dellinger (admitted pro hac vice)
`
`
` Attorney for Petitioners
`Edwards Lifesciences Corporation and
`Edwards Lifesciences LLC
`
`
`
`
`
`4
`
`

`

`IPR2020-01649
`Paper No. 24
`
`CERTIFICATE OF SERVICE
`
`Pursuant to 37 C.F.R. § 42.6(e), the undersigned certifies that on December
`
`
`
`
`1, 2021, a complete and entire copy of Petitioners’ Updated Exhibit List has been
`
`served in its entirety by e-mail on the following addresses of record for Patent
`
`Owner:
`
`Sarah E. Spires
`Paul J. Skiermont
`Skiermont Derby LLP
`1601 Elm St., Ste. 4400
`Dallas, TX 75201
`sspires@skiermontderby.com
`pskiermont@skiermontderby.com
`
`
`
`
`
`/s/ Brian P. Egan
`Brian P. Egan (Reg. No. 54,866)
`Attorney for Petitioners
` Edwards Lifesciences Corporation
`and Edwards Lifesciences LLC
`
`Dated: December 1, 2021
`
`
`
`
`
`
`
`
`5
`
`